Navigation Links
Catterton Partners Acquires Leading Cosmeceutical Brand StriVectin

GREENWICH, Conn., July 13 /PRNewswire/ -- Catterton Partners, one of the nation's leading consumer-focused private equity firms, today announced that, through a holding company, it has acquired the StriVectin brand and related assets from affiliates of Klein-Becker. Chrysallis, the premier management team in the beauty and personal care industry, led by Chief Executive Officer Melisse Shaban and Chief Marketing Officer Jill Scalamandre, will lead the new company. The partnership between Catterton and the Chrysallis management team marks another in a number of successful endeavors between the two groups, the most notable of which was Frederic Fekkai & Co., which was sold in 2008.

StriVectin is a leader in the global skincare market, which is expected to reach $58.2 billion by 2012, an increase of 17.6% since 2007.(1) Lauded as the "stretch-mark cream turned anti-wrinkle phenomenon" since being introduced in 2003, StriVectin is the fastest growing anti-aging brand and one of the top 20 prestige skincare brands in the United States.(2) Its clinically proven formulations have earned the enthusiasm of millions of consumers and top honors at the "Les Grands Prix Advantages de la Beaute" (Advantages Grand Prix of Beauty) in Paris. Today, the StriVectin line encompasses a range of anti-aging products with a targeted, problem-solution positioning, including StriVectin(R) Instant Facial Sculpting Cream, StriVectin-SD(R) Eye Cream, StriVectin(R) Neck Cream, and StriVectin(R)-WF Instant Deep Wrinkle Filler. StriVectin products are sold through leading retailers as well as direct marketing channels around the world, with the largest presence in the United States, France and the United Kingdom.

"The skincare market is no longer about aspirational luxury; it's about what works and in this regard, we see tremendous value in the StriVectin brand," said Ms. Shaban.

"StriVectin's record of profitable growth is a tribute to its customer centric marketing and targeted formulations, which helped create the cosmeceutical skincare category. With this transaction, we intend to build on these strengths and our own expertise to further enhance StriVectin's product portfolio and extend its global reach. We will be looking at new technologies to strengthen StriVectin's strong clinical positioning, thereby increasing value to the end consumer," continued Ms. Shaban.

"The StriVectin brand is well positioned for today's skincare consumer wanting efficacious, solution-focused skin treatments with proven results," said Ms. Scalamandre. "Currently, the brand experiences a loyal customer base that is highly engaged in the skincare category. These StriVectin enthusiasts provide an extraordinary word of mouth advocacy on the brand's authenticity and product efficacy. Going forward, we see opportunities to address a wider range of skincare needs for a more diverse base of consumers in a broader range of markets."

"We are very proud of what StriVectin has achieved, and are delighted that with this transaction, StriVectin will be part of a team that has a solid record of growing and nurturing powerful brands," said Gina Daines, Director of Marketing for Klein-Becker.

Highland Consumer Fund invested alongside Catterton Partners in the transaction. Terms of the transaction were not disclosed.

(1) Source: Datamonitor, February 12, 2009

(2) Source: NPD Group, April 2009

About Catterton Partners

With more than $2.3 billion under management, Catterton Partners is a leading private equity firm in the United States focused exclusively on the consumer industry. Since its founding in 1990, Catterton has leveraged its investment capital, strategic and operating skills, and network of industry contacts to establish one of the strongest investment track records in the consumer industry. Catterton invests in all major consumer segments, including Food and Beverage, Retail and Restaurants, Consumer Products and Services, and Media and Marketing Services. Catterton has led investments in companies such as Breyers Yogurt, Nature's Variety Pet Food, The Worth Collection, Build-A-Bear Workshop, Cheddar's Restaurants, P.F. Chang's China Bistro, Baja Fresh Mexican Grill, Frederic Fekkai, Wellness Pet Food, Kettle Foods, Odwalla and Heartland Recreational Vehicles. More information about the firm can be found at

About Chrysallis: The Beauty of Evolution

The Chrysallis management team was established to help grow innovative brands in the health and beauty category. Chrysallis's successes to date have included Frederic Fekkai & Co, LLC, a leading luxury salon, hair care brand, and provider of beauty products, Niadyne, Inc., a company dedicated to the discovery and development of uniquely efficacious topical products, and the Canyon Ranch YOUR TRANSFORMATION(TM) collection, a line of luxury skincare products focused on renewing, repairing and resisting skin damage from the inside and outside. Chrysallis is headquartered in New York, New York.

SOURCE Catterton Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CBCA Administrators, Inc. Announces Partnership with Bravo Wellness
2. RF Walsh Collaborative Partners Celebrates New Name & Expansion
3. Partnership for Prescription Assistance Prepared to Help Iowa Workers Hurt by Recession
4. Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results
5. Health Insurance Options for Domestic Partnerships
6. Portola Pharmaceuticals to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update
7. B-Line Medical(R) and Mentice, Inc. Announce Data Integration Partnership
8. Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients
9. Affinity VideoNet Partners With Providea Conferencing
10. Riverside Partners Completes Growth Equity Investment in Vocollect, the Leader in Voice Solutions for Supply-Chain and Healthcare Workforce Management
11. Whole Foods Market(R) Partners With Non-GMO Project to Label Companys Private Label Food Products Using New Third-Party Standard
Post Your Comments:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a ... sleep tracking systems. The new app features a more intuitive SleepScore™ that rates sleep ... well you slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the ...
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... ... , ... Today, Mothers Against Drunk Driving (MADD) learned that the ... the first time since 2011. In 2014, there were 9,967 fatalities involving an alcohol ... National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes in ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... -- Henry Schein, Inc., the world,s largest provider of health ... animal health practitioners, will unveil at the Greater New ... Pavilion , which brings together for the first time ... help any practice or laboratory enter the digital age. ... of experts appearing at the Pavilion. --> ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ ... "Company") (NYSE: MR ), a ... medical devices worldwide, today announced that ... general meeting of shareholders at the ... Grand Century, 193 Prince Edward West Road, ...
Breaking Medicine Technology: